Stoneridge Investment Partners LLC boosted its holdings in Exelon Co. (NASDAQ:EXC - Free Report) by 119.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,738 shares of the company's stock after purchasing an additional 55,426 shares during the quarter. Exelon makes up about 1.4% of Stoneridge Investment Partners LLC's investment portfolio, making the stock its 21st largest holding. Stoneridge Investment Partners LLC's holdings in Exelon were worth $3,829,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the business. Stephens Consulting LLC lifted its stake in Exelon by 78.1% in the fourth quarter. Stephens Consulting LLC now owns 782 shares of the company's stock valued at $29,000 after buying an additional 343 shares during the last quarter. Brown Lisle Cummings Inc. acquired a new stake in shares of Exelon in the 4th quarter worth about $30,000. Ashton Thomas Securities LLC acquired a new position in Exelon during the 3rd quarter valued at about $32,000. Crews Bank & Trust bought a new position in Exelon in the 4th quarter worth about $34,000. Finally, Versant Capital Management Inc increased its stake in shares of Exelon by 56.7% in the fourth quarter. Versant Capital Management Inc now owns 1,047 shares of the company's stock valued at $39,000 after purchasing an additional 379 shares during the period. Institutional investors own 80.92% of the company's stock.
In other news, EVP Colette D. Honorable sold 1,463 shares of the company's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares in the company, valued at $92,134.47. This represents a 39.18 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.10% of the company's stock.
EXC stock opened at $41.31 on Friday. The firm has a market cap of $41.51 billion, a PE ratio of 17.00, a P/E/G ratio of 2.74 and a beta of 0.56. Exelon Co. has a 12 month low of $33.35 and a 12 month high of $41.47. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The firm has a 50 day simple moving average of $38.37 and a 200 day simple moving average of $38.70.
Several analysts recently commented on EXC shares. Guggenheim upgraded Exelon from a "neutral" rating to a "buy" rating in a research report on Thursday, January 23rd. Barclays lowered their price target on Exelon from $44.00 to $42.00 and set an "overweight" rating on the stock in a report on Wednesday, January 22nd. Morgan Stanley decreased their target price on shares of Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a research report on Friday, November 22nd. Scotiabank boosted their price target on shares of Exelon from $40.00 to $42.00 and gave the stock a "sector perform" rating in a research report on Thursday, December 12th. Finally, Evercore ISI raised shares of Exelon from an "in-line" rating to an "outperform" rating and upped their price target for the stock from $43.00 to $44.00 in a research note on Tuesday, January 21st. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Exelon presently has a consensus rating of "Moderate Buy" and an average price target of $43.13.
Read Our Latest Research Report on EXC
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.